Charles River Laboratories International Inc. Stock Underperforms Monday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.
Charles River Laboratories International Inc. (CRL) shares fell 5.16% to $168.46 on Monday, marking the fourth consecutive day of losses. This decline occurred despite a positive trading session for the overall market, with the S&P 500 and Dow Jones both rising 0.19%. CRL's stock is now 26.40% below its 52-week high of $228.88. In comparison, competitors Labcorp Holdings Inc. and Alnylam Pharmaceuticals Inc. had mixed performances, while trading volume for CRL was below its 50-day average.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: MarketWatch Automated The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments